Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants.
Launay O, Gupta R, Machabert T, Konate E, Rousseau A, Vigne C, Beckers F, Devlin L, Botelho-Nevers E, Cachanado M, Chidiac C, Deplanque D, Dussol B, Ben Ghezala I, Lachatre M, Lacombe K, Laine F, Luong Nguyen LB, Pavese P, Schmidt-Mutter C, Tavolacci MP, Chicz RM, Coudsy B, Sridhar S, Touati A, Tartour E, Simon T.
Launay O, et al. Among authors: rousseau a.
Commun Med (Lond). 2025 Jan 18;5(1):21. doi: 10.1038/s43856-024-00675-9.
Commun Med (Lond). 2025.
PMID: 39827332
Free PMC article.